THE MCMANUS GROUP for ZIMMER BIOMET
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
H.R. 184 - Protection Medical Innovation Act of 2017. S. 108 - Medical Device Access and Innovation Protection. Sec. 211 of H.R. 1628 - American Health Care Act of 2017.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| BARRETT THORNHILL | — |
Health Issues HCR
Legislation and FDA regulation concerning medical device development, manufacturing, commercialization, and post-market regulation and activities. S. 404 - A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments for granting export certifications.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| BARRETT THORNHILL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.